Jeju Free International City Development Center (Acting Chairman Kwak Jin-gyu, hereinafter JDC) announced that Biosphero Co., Ltd., a company located in the Advanced Science and Technology Complex, has entered the Japanese market by signing an exclusive supply contract for the MPS (Micro Physiological System) platform with SPI (Summit Pharmaceuticals International), a Japanese pharmaceutical and bio distribution company.
Biosphero, a company specializing in organ-on-a-chip-based MPS, will exclusively supply its proprietary OrganXpert™ MPS platform to the Japanese market through this agreement. MPS is a next-generation non-clinical testing technology that simulates the human organ environment for new drug development and toxicity assessment. It is attracting attention as a core technology for alternative animal testing methods (NAMs) in the global pharmaceutical and biotech industries.
This agreement focuses on the supply of OrganXpert™ equipment to Japanese pharmaceutical companies, non-clinical CROs, and research institutions. The two companies also agreed to establish a mid- to long-term collaborative system, including joint sales and marketing, and technical support. SPI, a distribution company with key customers in Japan, serves global pharmaceutical companies and research institutions. This collaboration is expected to ensure the stable expansion of Biosphero's MPS technology into the Japanese market.
Biosphero sees this exclusive agreement as a starting point for global expansion, given that Japan is one of the markets where commercialization of MPS-based assessment technology is actively being discussed. Indeed, since signing the agreement, Biosphero has participated in MPS-related academic conferences and industry events held in Japan, officially exhibiting and promoting OrganXpert™ and highlighting its technological strengths.
This achievement is considered a result of JDC's growth support policy for companies in its advanced science and technology complexes. JDC has been providing tailored, step-by-step support to companies in its advanced science and technology complexes, including technology commercialization support, global partnerships, and overseas market development.
Koo Byung-wook, head of JDC’s Industrial Promotion Headquarters, said, “This exclusive contract with Japan is an example of a company’s technological prowess and JDC’s growth support policy combining to advance into the global market,” adding, “We will continue to support small and medium-sized enterprises based on advanced technologies to strengthen their global competitiveness.”
This contract is evaluated as an example of domestic MPS technology being linked to an exclusive commercial partnership in the Japanese market amidst the global NAMs policy shift, and is an example of the achievements of a technology-based SME growth ecosystem.
You must be logged in to post a comment.